Allied Market Research recently published a report, titled, “Immunosuppressants Market by Drug class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, and Others), Indication (Organ Transplantation, Autoimmune Disorders, and Non-Autoimmune Inflammatory Diseases), and Distribution channel (Hospital pharmacies, Retail pharmacies and Online pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026.” According to the analyst of AMR, the global immunosuppressants industry was estimated at $13.89 billion in 2018 and is expected to hit $42.51 billion by 2026, registering a CAGR of 14.7% from 2019 to 2026.
Immunosuppressants Market Overview–
Increase in autoimmune disorders, and surge in demand for organ transplantation drive the growth of the global immunosuppressant market. On the other hand, lack of awareness toward organ transplantation impedes the growth to certain extent. However, several growth prospects in emerging
economies have created a number of opportunities for the key players in the industry.
Request Sample Report at:
Immunosuppressants Market Segmentation:
The autoimmune disorders segment to maintain the lion’s share during the study
Based on indication, the autoimmune disorders segment contributed to nearly half of the global immunosuppressant market revenue in 2018, and is anticipated to rule the roost during 2019–2026. Rise in prevalence of autoimmune disorders such as arthritis across the globe has boosted the growth of the segment. The organ transplantation segment, on the other hand, would showcase the fastest CAGR of 15.5% till 2026. Surge in use of these drugs during organ transplantation has propelled the growth of the segment.
The calcineurin inhibitors segment to retain its dominance by 2026-
Based on drug class, the calcineurin inhibitors segment accounted for nearly one-third of the global immunosuppressant market share in 2018, and is expected to dominate throughout the forecast period. The same segment is also anticipated to grow at the fastest CAGR of 16.2% by 2026. This is due to
increased adoption of these drugs during organ transplantation. It’s also helpful in treating autoimmune disorders.
North America held the major share in 2018-
Based on geography, North America held the highest share in 2018, generating more than two-fifths of the global immunosuppressant market. This is attributed to increase in incidence of auto-immune disorders in this province. Simultaneously, the region across LAMEA would cite the fastest CAGR of 16.7% during the estimated period. Rise in healthcare expenditure, surge in
disposable incomes, and government measures toward making immunosuppressant drugs available for patients contribute to the market growth.
For Purchase Enquiry at:
Immunosuppressants Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Immunosuppressants Market Report:
What is the Immunosuppressants market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Immunosuppressants?
Key market players discussed in the Immunosuppressants Market report include Astellas Pharma, Inc., Bristol Myers Squibb, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc., Intas Pharmaceuticals Ltd., Johnson & Johnson, Mylan Laboratories Inc., Novartis AG, Pfizer, Inc., Sanofi S.A..
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Regenerative Medicine Market Size, Share & Growth Outlook 2022-2030
Wearable Patch Market Size, Share & Growth Outlook 2022-2030
Dental Implants and Prosthetics Market Size, Share & Growth Outlook 2022-2030
IVF Devices and Consumables Market Size, Share & Growth Outlook 2022-2030
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.